LGND
Ligand Pharmaceuticals, Inc.
Halal Rating :
Last Price
$111.69
Last updated:
Market Cap
$2.11b
7D Change
5.51%
1 Year Change
52.19%
Company Overview
Industries
Exchange
Nasdaq
Next Earnings Date
Ligand Pharmaceuticals is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. The company has partnerships with pharmaceutical and biotechnology companies and generates revenue through licensing fees, milestone payments, and royalties from the sales of products using its technologies.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $51.81m | $49.41m | - | $741000.0 | 0.00% | 1.50% |
| June 30, 2024 | $41.53m | $61.9m | - | $1.27m | 0.00% | 2.05% |
| March 31, 2024 | $30.98m | $28.13m | - | $141000.0 | 0.00% | 0.50% |
Company Impact
Help us evaluate Ligand Pharmaceuticals, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.